search
close_mark

Frederick Cope

Frederick Cope

26 Jun, 2025

ā€œCelegenceā€™s expert publishing team allowed us to submit our briefing book and other documents to the US FDA in eCTD format, thereby reducing dependencies on our core team and allowing them to focus on more strategic initiatives.ā€

Miriam Tenorio
Read Now

Other Related Articles

Devices Incorporating Tissues or Cells of Animal or Human Origin, or Their Derivatives: Data Expectations Under EU MDR
Blog Medical Devices

Devices Incorporating Tissues or Cells of Animal or Human Origin, or Their Derivatives: Data Expectations Under EU MDR

13 May, 2026

Nitrosamine Control Insights: Clarity and Control in EU Risk Assessment
Blog Pharmaceutical

Nitrosamine Control Insights: Clarity and Control in EU Risk Assessment

07 May, 2026

PMCF Under MDR: When is a Healthcare Professional Survey Approach Justifiable?
Blog Medical Devices

PMCF Under MDR: When is a Healthcare Professional Survey Approach Justifiable?

29 Apr, 2026

Dental Medical Devices: Special Considerations for Clinical Evaluation Under EU MDR
Blog Medical Devices

Dental Medical Devices: Special Considerations for Clinical Evaluation Under EU MDR

22 Apr, 2026

MDR Article 117: What It Means ā€” And How We Help You Get Ahead
Blog Medical Devices

MDR Article 117: What It Means ā€” And How We Help You Get Ahead

16 Apr, 2026

Heavy Metals in Pharmaceuticals: A Critical Quality and Safety Imperative
Blog Pharmaceutical

Heavy Metals in Pharmaceuticals: A Critical Quality and Safety Imperative

10 Apr, 2026

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era
Blog Pharmaceutical

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era

01 Apr, 2026

Expanded Access Approval : Balancing Urgency and Oversight in Regulatory Affairs
Blog Pharmaceutical

Expanded Access Approval : Balancing Urgency and Oversight in Regulatory Affairs

26 Mar, 2026

View All